Alamar Biosciences, Inc.
ALMRNASDAQHealthcareBiotechnology
Regular session
$33.6799
−$0.5601 · -1.64%
ALMR company overview
Regular session · ET · Market data may be delayed.
Company profile
Alamar Biosciences operates as a commercial-stage proteomics firm, specializing in the highly sensitive, simultaneous identification of various proteins for both scientific research and prospective medical applications. Their integrated platform brings together proprietary instruments, specialized consumables, and unique software, forming a comprehensive, end-to-end solution. This system is designed for accurately quantifying multiple proteins, particularly those present in low concentrations, across a wide array of research and potential clinical uses.
- Industry
- Biotechnology
- Sector
- Healthcare
- Headquarters
- US
- CEO
- Yuling Luo
- Listed since
- Apr 17, 2026
- Employees
- 222
Market position
Day range
Current $33.6799
52-week range
Current $33.6799
- Open
- $34.07
- Previous close
- $34.24
- Volume
- 72.57K
- 0.2× average
- Average volume
- 368.27K
- Average daily volume
- Market cap
- 2.33B USD
- Beta
- -6.18
- Market reference 1
- 50-day average
- $26.8384
- +25.49% above average
- 200-day average
- $24.8957
- +35.28% above average
Financials
Financial snapshot
Latest / TTMValuation & yield
- P/E (TTM)
- -63.55×
- P/B (TTM)
- 6.32×
- P/S (TTM)
- 42.09×
- Dividend yield
- 0.00%
Profitability & efficiency
- Gross margin
- 58.01%
- Operating margin
- -46.66%
- Net margin
- -62.25%
Financial health
- Debt / equity
- 0.16×
Earnings
- EPS beat rate
- 50%
- 1 beat, 1 miss, 0 met estimates
- Average EPS surprise
- +13.39%
- 2 comparable reports
- Latest EPS result
- -0.22
- Estimate -0.31 · Beat by 28.54%
EPS: actual versus estimate
Recent quarterly results
Revenue: actual versus estimate
Recent quarterly results
ALMR peers
Continue in GoAI
Research ALMRresearch.disclaimer